Page last updated: 2024-08-21

pyrimidine and B-Cell Chronic Lymphocytic Leukemia

pyrimidine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Almasan, A; Erzurum, SC; Hill, BT; Janocha, AJ; Sharma, A; Smith, MR	1

Other Studies

1 other study(ies) available for pyrimidine and B-Cell Chronic Lymphocytic Leukemia

Article	Year
Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells. Molecular cancer research : MCR, 2014, Volume: 12, Issue:9 Topics: B-Lymphocytes; Cell Line, Tumor; Drug Resistance, Neoplasm; Glycolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Oxidative Phosphorylation; Pyrimidines; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Vidarabine	2014

Article

Year

Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.

Molecular cancer research : MCR, 2014, Volume: 12, Issue:9

Topics: B-Lymphocytes; Cell Line, Tumor; Drug Resistance, Neoplasm; Glycolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Oxidative Phosphorylation; Pyrimidines; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Vidarabine

2014